Abstract: The present invention relates to a pharmaceutical composition for the prevention and/or the treatment of dialysis-induced hypotension and/or hypotension after dialysis which comprises, as an active ingredient, a pyrazolopyridine compound of the following formula
wherein the groups R1, R2 R3, or a said thereof are herein defined.